Posttranscriptional methylation of the 16S rRNA aminoglycoside binding site, common in aminoglycoside-producing microorganisms, has been described in nosocomial isolates highly resistant to all clinically available aminoglycosides. Currently, seven plasmid-mediated 16S rRNA methyltransferase (16S-methylase) genes have been identified: armA, npmA, rmtA, rmtB, rmtC, rmtD (named rmtD1 herein), and very recently, rmtE, from bovine origin (3, 4, 19) . To date, only Klebsiella pneumoniae harboring rmtD1 has been reported in Argentina (7) . Herein, a nationwide survey of aminoglycoside resistance mediated by 16S-methylases among enterobacteria in Argentina was performed.
(Preliminary data were presented in abstract form at the 109th General Meeting, American Society for Microbiology, 2009 , and at the 50th Interscience Conference on Antimicrobial Agents and Chemotherapy, American Society for Microbiology, 2010.)
Susceptibility and molecular detection of resistance mechanisms. To determine the prevalence of the 16S-methylases, a collection of 1,064 consecutive, nonduplicate enterobacterial isolates was analyzed. This sample set was collected during a 5-day period in 2007 from 66 hospitals belonging to the WHONET-Argentina Resistance Surveillance Network and submitted to the Servicio Antimicrobianos (the Argentinian National Reference Laboratory). Initial screening of 16S-methylase activity was performed using the disc diffusion susceptibility method for amikacin and gentamicin (inhibition zones of Յ10 mm) (1, 4) . Although almost 80% of the collection was made up of Escherichia coli and Klebsiella spp., only 12 isolates belonging to other species (4 Enterobacter cloacae, 1 Enterobacter aerogenes, 3 Serratia species, 2 Citrobacter freundii, 1 Morganella morganii, and 1 Proteus mirabilis isolate) met the screening criteria used. Of these, 5 showed inhibition zones of Ն7 mm to amikacin, and 7 (all of the Enterobacter species and C. freundii isolates) showed an absence of inhibition zones for both aminoglycosides. Only these last 7 isolates gave positive results when tested for 16S-methylase genes by PCR (Table 1) , and only the primers against rmtD genes rendered amplicons (Table 2) . Complete gene amplification and DNA sequencing showed a unique 16S-methylase gene in these 7 isolates. This gene displayed 97.3% nucleotide identity (20 nucleotides of difference) and 96.4% amino acid identity (9 residues of difference) with rmtD1. Since this is the first description of a 16S-methylase gene allele, it was named rmtD2, as recommended by Doi and colleagues (6) . The rmtD2-harboring isolates were from 6 hospitals in 4 geographic areas across Argentina, and pulsed-field gel electrophoresis (PFGE) of XbaI-digested DNA of the 4 E. cloacae and 2 C. freundii isolates showed that they were not clonally related (data not shown).
Antibiotic MICs, except that of apramycin (agar dilution method [1] ), were determined by Etest (AB bioMérieux, Solna, Sweden). The 7 rmtD2-harboring isolates showed high MICs to all of the aminoglycosides tested except apramycin (Table 2) . These results were comparable with those of Fritsche and colleagues for enterobacteria producing different enzymes that methylate the 16S rRNA at position G1405 (7) . Conversely, Wachino and colleagues described NpmA, which methylates at position A1408, conferring intermediate resistance to amikacin (16 g/ml) and low-level resistance to gentamicin (32 g/ml) but high-level resistance to apramycin (Ͼ256 g/ml) (19) .
Taken together, these data suggest that the new variant RmtD2 methylates at position G1405. Moreover, our phenotypic results support the approach of Doi and Arakawa for detecting the 16S-methylases that act at that last position (4) .
The rmtD2-harboring isolates displayed other resistance mechanisms ( Table 2 ). Under the new carbapenem breakpoints (2), all 7 clinical strains showed resistance/intermediate resistance to ertapenem, and several of them showed intermediate resistance to imipenem and/or meropenem. This is probably due to impermeability combined with hyperproduced AmpC and/or CTX-M-type enzymes (11, 16) . Production of metallo-␤-lactamases was discarded by EDTA-sodium mercaptoacetic acid (SMA) phenotypic screening (8) . All of the isolates were resistant to ciprofloxacin (Q4079 showed reduced susceptibility), tetracycline, and chloramphenicol as well. Biparental conjugations were performed between each rmtD2-harboring clinical isolate and sodium azide-resistant E. coli J53 or rifampin-and nalidixic acid-resistant E. coli ER1793 as recipients, using amikacin (50 g/ml) and gentamicin (50 g/ ml) plus sodium azide (100 g/ml) or rifampin (300 g/ml), respectively, to select the transconjugants. All conjugations rendered rmtD2-harboring transconjugants highly resistant to aminoglycosides ( Table 2) . Resistance to ampicillin, piperacillin, extended-spectrum cephalosporins, and chloramphenicol was cotransferred to E. coli in some cases. Transmission of reduced susceptibility to ciprofloxacin was observed in the transconjugant J-4143. The characterization of relevant genetic determinants responsible for these resistant phenotypes, such as bla TEM-1 , bla CTX-M-2 , and qnrB10, was performed by PCR and DNA sequencing (Tables 1 and 2 ). Therefore, RmtD2 was coexpressed with, but not necessarily linked to, other resistance mechanisms. rmtD2 flanking regions. XbaI DNA libraries from E. cloacae Q4010, E. aerogenes Q4079, and C. freundii Q1174 were generated in E. coli TOP10 using the cloning vector pACYC184. The rmtD2-harboring clones were selected with chloramphenicol (34 g/ml), gentamicin, and kanamycin (4 g/ml each), and DNA inserts were sequenced using pACYC184-specific and sequence-based primers. The inserts from isolates Q4010 and Q1174 were completely sequenced, while a 19.7-kb partial sequence was obtained from a longer fragment of Q4079. The genetic environments of rmtD2 in these three isolates differed only in the cassette arrays of the class 1 integrons and showed the same ISCR14-bracketed genetic architecture as those surrounding rmtD1 in Pseudomonas aeruginosa PA0905 and K. pneumoniae R2 from Brazil (5) (Fig. 1A) . However, several key differences between the environments of rmtD1 and rmtD2 were found (Fig. 1B to D) . We concluded that the ISCR14-bracketed structures surrounding rmtD1 and rmtD2 are composed of very similar blocks of genes but having different edges. Moreover, it is noteworthy that the second ISCR14 in E. aerogenes Q4079, named herein ISCR14B, is actually a chimera, since the last 337 nucleotides of orf494 and its 256-bp downstream sequence to oriIS showed a maximal identity of 96% with ISCR5B (GenBank accession no. AM849110) but only 79% with ISCR14 (9). Therefore, ISCR14B might have resulted from a recombination between two ISCRs (e.g., ISCR14 and ISCR5B), as has already been reported for ISCR5B, which is itself a chimeric element (9) . All of the data strongly suggest that the ISCR14-bracketed region found in the enterobacterial isolates from Argentina and that in P. aeruginosa PA0905 from Brazil were assembled in independent processes through a series of ISCR transposition/homologous recombination events rather than variants derived from a common original structure. This is similar to the proposed model of the ISCR19-bracketed bla OXA-18 structure (12) . To the best of our knowledge, this is the first report of a 16S-methylase gene linked to a Tn21-like element (Fig. 1A) . Another Tn21-like transposon containing the same class 1 integron (dfrA12-orfF-aadA2) as that found in E. aerogenes Q4079 was previously described in a 65-kb conjugative plasmid from a fecal E. coli isolate (20) . Unlike in this plasmid, the Tn21-like element of Q4079 has its terminal inverted repeat at the tnp end (TIR tnp21 ) disrupted by the insertion of IS4321R (Fig. 1A) . However, it was shown that the precise excision of IS4321 can re-create the original TIR tnp21 , allowing Tn21 transposition (14) . In E. aerogenes Q4079, the Tn21-like element is inserted in the same genetic context as Tn21 in the 94-kb multiresistant plasmid NR1 (R100) of Shigella flexneri, i.e., upstream of the ybjA gene and disrupting a Tn9 homolog (10, 20) (Fig. 1A) . Since the Tn21-harboring Tn9 element of NR1 is itself transposable as Tn2670 (10), the location of rmtD2 in a putative Tn2670-like element constitutes another potential means of dissemination. In summary, the finding of rmtD2 in this genetic context suggests that its dissemination could be highly facilitated.
Prevalence of rmtD2. We observed an rmtD2 prevalence of 0.7% in Enterobacteriaceae. Considering the distribution of species in the collection studied, the prevalence rates of this gene were 9.3% in Enterobacter spp. and 13.3% in Citrobacter spp. To better estimate these rates across a broader time period, an analysis of the WHONET-Argentina database (year 2007, 19,077 enterobacteria) was performed. The total corre- lation between the presence of rmtD2 and the absence of inhibition zones for both amikacin and gentamicin was used as an indicator of the presence of this gene. As observed in the surveillance collection, the overall prevalence of rmtD2 was low (2.1%) but significantly higher in Enterobacter spp. and Citrobacter spp. than in other enterobacteria (Table 3 ), suggesting a possible reservoir in these species.
In order to establish a continuous surveillance, the National Reference Laboratory had recommended to the WHONETArgentina hospitals to search for enterobacterial isolates showing an absence of inhibition zones for both amikacin and gentamicin. Twelve strains (4 E. cloacae, 1 Enterobacter agglomerans, 1 C. freundii, 4 K. pneumoniae, and 2 P. mirabilis strains), isolated from January 2008 to April 2009, were selected for molecular characterization. By PCR screening, 10/12 isolates were positive only for rmtD genes. The 2 P. mirabilis isolates were negative for all of the 16S-methylase genes tested and remain under study. By sequencing, rmtD1 was found in 2 K. pneumoniae isolates, while rmtD2 was observed in the remaining 8 isolates.
rmtD2 has been present in Argentina for more than a decade. The first 16S-methylase producer described in Argentina was a K. pneumoniae strain isolated in 2005 (7). To determine whether this resistance mechanism was present earlier, 153 AmpC-producing enterobacterial strains isolated in 1996 to 1998 from a previous national survey were analyzed (15) . Thirteen isolates (1 Enterobacter sp., 8 E. cloacae, 3 C. freundii, and 1 Serratia marcescens isolate) were highly resistant to amikacin and gentamicin (MICs of Ͼ256 g/ml). Four of them (2 E. cloacae, 1 C. freundii, and 1 S. marcescens isolate), selected for 16S-methylase gene characterization, showed rmtD2 only. These results point out the presence of rmtD2 in Enterobacter spp. and C. freundii isolated in the 1990s and strengthen the hypothesis of a reservoir in these species, with a further dissemination to other enterobacteria, such as K. pneumoniae. This presumption indicates that continued surveillance is necessary to monitor the spread of rmtD genes.
Nucleotide sequence accession numbers. The nucleotide sequences determined here have been assigned GenBank accession numbers HQ401565 (E. aerogenes Q4079), HQ401566 (E. cloacae Q4010), and HQ401567 (C. freundii Q1174). 
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